Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07FFL
|
||||
| Former ID |
DNC009073
|
||||
| Drug Name |
ADOCIAQUINONE B
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H17NO6S
|
||||
| Canonical SMILES |
CC12CCCC3=COC(=C31)C(=O)C4=C2C=C5C(=C4)C(=O)C6=C(C5=O)S<br />(=O)(=O)CCN6
|
||||
| InChI |
1S/C22H17NO6S/c1-22-4-2-3-10-9-29-20(15(10)22)18(25)13-7-11-12(8-14(13)22)19(26)21-16(17(11)24)23-5-6-30(21,27)28/h7-9,23H,2-6H2,1H3/t22-/m0/s1
|
||||
| InChIKey |
KJMXEMKLXNMFIG-QFIPXVFZSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | M-phase inducer phosphatase 2 | Target Info | Inhibitor | [1] | |
| Dual specificity protein phosphatase 1 | Target Info | Inhibitor | [2] | ||
| KEGG Pathway | MAPK signaling pathway | ||||
| Cell cycle | |||||
| Progesterone-mediated oocyte maturation | |||||
| MicroRNAs in cancerhsa04010:MAPK signaling pathway | |||||
| Serotonergic synapse | |||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| Wnt Signaling PathwayNetPath_25:FSH Signaling Pathway | |||||
| EGFR1 Signaling Pathway | |||||
| Wnt Signaling Pathway | |||||
| TCR Signaling Pathway | |||||
| Pathway Interaction Database | PLK1 signaling events | ||||
| FOXM1 transcription factor network | |||||
| p38 signaling mediated by MAPKAP kinases | |||||
| Aurora A signalingfcer1pathway:Fc-epsilon receptor I signaling in mast cells | |||||
| Regulation of p38-alpha and p38-beta | |||||
| Direct p53 effectors | |||||
| ErbB1 downstream signaling | |||||
| ATF-2 transcription factor network | |||||
| AP-1 transcription factor network | |||||
| Reactome | Cyclin B2 mediated events | ||||
| Cyclin A/B1 associated events during G2/M transition | |||||
| Cyclin A:Cdk2-associated events at S phase entryR-HSA-112409:RAF-independent MAPK1/3 activation | |||||
| Negative regulation of MAPK pathway | |||||
| WikiPathways | Senescence and Autophagy in Cancer | ||||
| MAPK Signaling Pathway | |||||
| Retinoblastoma (RB) in Cancer | |||||
| Prostate Cancer | |||||
| Integrated Breast Cancer Pathway | |||||
| Integrated Cancer pathway | |||||
| Mitotic G2-G2/M phases | |||||
| Cell CycleWP382:MAPK Signaling Pathway | |||||
| References | |||||
| REF 1 | Bioorg Med Chem. 2008 Oct 1;16(19):9040-9. Epub 2008 Aug 7.Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties. | ||||
| REF 2 | Bioorg Med Chem. 2009 Mar 15;17(6):2276-81. Epub 2008 Nov 8.Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.